Get the Stockscreener App
14.00
2.04%
0.28
After Hours:
14.01
0.010
+0.07%
Gh Research Plc stock is traded at $14.00, with a volume of 233.70K.
It is up +2.04% in the last 24 hours and up +5.11% over the past month.
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.
See More
Previous Close:
$13.72
Open:
$13.7
24h Volume:
233.70K
Relative Volume:
0.78
Market Cap:
$728.39M
Revenue:
-
Net Income/Loss:
$-41.43M
P/E Ratio:
-17.72
EPS:
-0.79
Net Cash Flow:
$-39.97M
1W Performance:
+3.70%
1M Performance:
+5.11%
6M Performance:
+40.28%
1Y Performance:
+56.08%
1-Day Range:
$13.44
$14.62
1-Week Range:
$13.21
$15.31
52-Week Range:
$6.72
$20.50
Gh Research Plc Stock (GHRS) Company Profile
Compare GHRS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GHRS
Gh Research Plc
|
14.00 | 851.04M | 0 | -41.43M | -39.97M | -0.79 |
|
VRTX
Vertex Pharmaceuticals Inc
|
437.15 | 110.25B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
693.50 | 73.04B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
449.16 | 59.98B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
907.98 | 54.90B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
193.22 | 40.73B | 447.02M | -1.18B | -906.14M | -6.1812 |
Gh Research Plc Stock (GHRS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-13-25 | Initiated | Needham | Buy |
| Jun-04-25 | Resumed | Cantor Fitzgerald | Overweight |
| Mar-13-25 | Initiated | Guggenheim | Buy |
| Mar-07-25 | Initiated | RBC Capital Mkts | Outperform |
| Feb-13-25 | Initiated | Cantor Fitzgerald | Overweight |
| Aug-16-22 | Initiated | H.C. Wainwright | Buy |
| Jun-16-22 | Initiated | ROTH Capital | Buy |
View All
Gh Research Plc Stock (GHRS) Latest News
Understanding GH Research PLC’s price movementWeekly Stock Recap & Safe Investment Capital Preservation Plans - newser.com
Live market analysis of GH Research PLCMarket Growth Report & High Conviction Investment Ideas - newser.com
GH Research PLC stock chart pattern explainedWeekly Investment Recap & Free AI Powered Buy and Sell Recommendations - newser.com
Is GH Research PLC showing signs of accumulationPortfolio Risk Report & Risk Controlled Swing Trade Alerts - newser.com
Can GH Research PLC (1KA) stock deliver consistent EPS growthAnalyst Downgrade & High Conviction Trade Alerts - newser.com
Is GH Research PLC stock oversold or undervaluedPortfolio Gains Summary & Fast Gain Swing Trade Alerts - newser.com
What data driven models say about GH Research PLC’s futureWeekly Investment Report & Precise Swing Trade Entry Alerts - newser.com
Historical volatility pattern of GH Research PLC visualizedDividend Hike & Consistent Income Trade Ideas - newser.com
How sustainable is GH Research PLC stock dividend payoutQuarterly Portfolio Report & Weekly Chart Analysis and Guides - newser.com
Is GH Research PLC stock dividend yield sustainableJuly 2025 Weekly Recap & Reliable Intraday Trade Plans - newser.com
Perhaps timely catching GH Research PLC (GHRS) would be a good idea - setenews.com
HC Wainwright Has Lowered Expectations for GH Research (NASDAQ:GHRS) Stock Price - Defense World
HC Wainwright & Co. Maintains GH Research (GHRS) Buy Recommendation - MSN
GHRS | GH Research PLC Ordinary Stock Data, Price & News - Quiver Quantitative
Will GH Research PLC stock deliver long term returnsJuly 2025 Update & AI Forecast Swing Trade Picks - newser.com
What’s next for GH Research PLC stock price2025 Price Action Summary & AI Based Trade Execution Alerts - newser.com
Wall Street Analysts Think GH Research (GHRS) Could Surge 130.59%: Read This Before Placing a Bet - Finviz
GHRS: HC Wainwright Adjusts Price Target to $35, Maintains Buy R - GuruFocus
Is GH Research PLC stock attractive for income investors2025 Major Catalysts & Fast Exit and Entry Strategy Plans - newser.com
Why GH Research PLC (1KA) stock remains stableShare Buyback & Precise Trade Entry Recommendations - newser.com
GH Research to Engage at Stifel 2025 Healthcare Conference - MSN
Is GH Research PLC stock a safe buy before earningsJuly 2025 WrapUp & AI Powered Buy/Sell Recommendations - newser.com
GH Research (NASDAQ:GHRS) Rating Lowered to Sell at Wall Street Zen - Defense World
Gh Research Plc Stock (GHRS) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.43%
0.07%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):